Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly

Purpose Recent data indicate that extended dosing intervals (EDIs) with lanreotide autogel 120 mg are effective and well-received among patients with acromegaly who have achieved biochemical control with monthly injections of long-acting somatostatin analogues (SSAs). We further evaluated the effect...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine 2020-12, Vol.70 (3), p.575-583
Hauptverfasser:	Bernabéu, Ignacio, Fajardo, Carmen, Marazuela, Mónica, Cordido, Fernando, Venegas, Eva María, de Pablos-Velasco, Pedro, Maroto, Gonzalo Piedrola, Olvera, María Pilar, de Paz, Isabel Pavón, Carvalho, Davide, Romero, Carme, De la Cruz, Guillermo, Escolá, Cristina Álvarez
Format:	Artikel
Sprache:	eng
Schlagworte:	Acromegaly - drug therapy Cross-Sectional Studies Delayed-Action Preparations - therapeutic use Diabetes Endocrinology Human Growth Hormone - therapeutic use Humanities and Social Sciences Humans Insulin-Like Growth Factor I Internal Medicine Medicine Medicine & Public Health Middle Aged multidisciplinary Original Original Article Peptides, Cyclic - therapeutic use Quality of Life Science Somatostatin - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!